# A Trial to Compare the Pharmacodynamic and Pharmacokinetic Properties of Biochaperone® Combo With Humalog® Mix25 and With Simultaneous Injections of Humalog® and Lantus® in Subjects With Type 2 Diabetes

> **NCT02514850** · PHASE1 · COMPLETED · sponsor: **Adocia** · enrollment: 24 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** Biochaperone Combo
- **DRUG:** Humalog Mix25
- **DRUG:** Humalog
- **DRUG:** Lantus
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02514850
- **Lead sponsor:** Adocia
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07
- **Primary completion:** 2015-11
- **Final completion:** 2015-11
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2015-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02514850

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02514850, "A Trial to Compare the Pharmacodynamic and Pharmacokinetic Properties of Biochaperone® Combo With Humalog® Mix25 and With Simultaneous Injections of Humalog® and Lantus® in Subjects With Type 2 Diabetes". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT02514850. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*